Loading
ODAIA
ODAIA is a Toronto-based AI company founded in 2018, specializing in AI-powered commercial intelligence for the life sciences and pharmaceutical industry. The company aims to enhance engagement between pharmaceutical companies and healthcare providers, ultimately reducing the time patients wait to access therapies. ODAIA's flagship product, MAPTUAL, is an AI-driven cloud software platform that integrates data science and machine learning to provide commercial insights and automate processes. MAPTUAL offers features such as predictive analytics, customer journey intelligence, and omnichannel attribution, enabling organizations to optimize interactions with healthcare professionals. ODAIA serves B2B clients, including Fortune 500 life science companies and healthcare organizations, helping them analyze patient journeys and improve engagement strategies. With a focus on human-centric software, ODAIA stands out in the industry by fostering meaningful interactions rather than purely transactional ones. The company has raised $44.48 million in funding and operates offices in Toronto and Boston.
Funding
Every round, secondary, debt facility or acquisition involving ODAIA that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
$15M